medigraphic.com
ISSN 1029-3019 (Electronic)

2014, Number 02

<< Back Next >>

MediSan 2014; 18 (02)

Main clinical and epidemiological aspects in patient with dermopathies due to drugs

López PN, Tablada RME, Baltazar GA, Jacas PAL, Tassé VOL

Language: Spanish
References: 20
Page: 165-171
PDF size: 133.32 Kb.


ABSTRACT

A descriptive, cross sectional and prospective study of the 51 patients with dermopathies due to drugs, admitted to the Dermatology Service of "Dr. Juan Bruno Zayas Alfonso" Teaching General Hospital in Santiago de Cuba was carried out from January, 2011 to December, 2012, to determine the clinical and epidemiological characteristics of them. For this purpose, the variables age, sex, clinical pattern, ingested drugs and administration route, person who indicated the drug, among others, were analyzed. The skin eruptions due to drugs were presented in a wide clinical variety, with prevalence of the minor multiform erythema, the treatment was indicated by doctors in most of the cases, and among the groups of consumed drugs with more frequency there were the antimicrobians and the non steroids analgesic anti-inflammatory drugs.


REFERENCES

  1. Rondón Lugo AJ. Temas dermatológicos: pautas diagnósticas y terapéuticas. Caracas: Editorial Feimpress; 2001. p. 277-88.

  2. Ruiz I, Pinilla E. La piel y los efectos adversos de los medicamentos. Aspectos generales de farmacovigilancia. Rev Chil Dermatol. 2007; 13(2): 119-24.

  3. Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W. Potential role of pharmacogenomics in reducing adverse drug reactions. JAMA. 2001; 286(18): 2270- 9.

  4. Christel Bolte M. Reacciones adversas a medicamentos en Dermatología. Revista Médica CLC. 2002 [citado 19 Mar 2013]; 13(3). Disponible en: http://www.clc.cl/ Dev_CLC/media/Imagenes/PDF%20revista%20m%C3%A9dica/2002/3%20julio/Reac cionesAdversas-5.pdf

  5. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30(2): 239-45.

  6. Organización Mundial de la Salud. La farmacovigilancia: garantía de seguridad en el uso de los medicamentos. Ginebra: OMS; 2004.

  7. Manssur J, Díaz Almeida J, Cortés M. Dermatología. La Habana: Editorial Ciencias Médicas; 2002. p. 90-4.

  8. Castagnino JP, Musella RM, Palmero D. Síndrome DRESS inducido por fármacos antituberculosos. Rev Am Med Respir. 2011; 11(3): 141-6.

  9. Flórez J. Farmacología humana. 3 ed. Barcelona: Masson; 1997.

  10. Fernández Hernández-Baquero G. Dermatología. La Habana: Editorial Científico- Técnica; 1986. p. 21-389.

  11. Fitzpatrick TB. Dermatología en medicina general. 6 ed. México, D.F.: Editorial Médica Panamericana; 2005. p. 832-51.

  12. Figueras A, Capella D, Castel JM, Laorte JR. Spontaneous reporting of adverse drug reactions to non-steroidal anti-inflammatory drugs. A report from the Spanish System of Pharmacovigilance, including an early analysis of topical and enteric-coated formulations. Eur J Clin Pharmacol. 1994; 47(4): 297-303.

  13. Giachetto G, Danza A, Lucas L, Cristiani F, Cuñetti L, Vázquez X, et al. Hospitalizaciones por reacciones adversas a medicamentos y abandono del tratamiento farmacológico en el hospital universitario. Rev Med Urug. 2008; 24(2): 102-8.

  14. Ding WY, Lee CK, Choon SE. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia. Int J Dermatol. 2010; 49(7): 834-41.

  15. Bobadilla González P, Prados Castaño MJ. Manual de alergia a medicamentos para profesionales de atención primaria. Badajoz: Laboratorios Menarini; 2007. p. 34-6.

  16. Puche Cañas E, Luna del Castillo JD. Reacciones adversas a medicamentos en pacientes que acudieron a un hospital general: un meta-análisis de resultados. An Med Interna (Madrid). 2007; 24(12): 574-8.

  17. Estrella V, Baroni E, Leroux MB, Sánchez A, Bergero A, Fernández Bussy R. Síndrome de hipersensibilidad a anticonvulsivantes (SHA). Rev Argent Dermatol. 2007 [citado 24 Mar 2013]; 8(1). Disponible en: http://www.scielo.org.ar/scielo. php?script=sci_ arttext&pid=S1851-300X2007000100005

  18. Danza A, López M, Vola M, Álvarez-Rocha A. Reacciones adversas cutáneas a medicamentos. Vigilancia durante un año en un Hospital Universitario. Uruguay 2008- 2009. Rev Med Chile. 2010; 138(11): 1403-9.

  19. Narbona B, Moreno M, Díaz M. Síndrome de hipersensibilidad a drogas. Dermatología Argentina. 2005; 11(3): 211.

  20. Posadas SJ, Pichler WJ. Delayed drug hypersensitivity reactions- new concepts. Clin Exp Allergy. 2007; 37(7): 989-99.




2020     |     www.medigraphic.com